2.73
-0.13(-4.55%)
Currency In USD
| Previous Close | 2.86 |
| Open | 2.8 |
| Day High | 2.86 |
| Day Low | 2.72 |
| 52-Week High | 6.2 |
| 52-Week Low | 1.33 |
| Volume | 174,270 |
| Average Volume | 1.57M |
| Market Cap | 26.01M |
| PE | -2.22 |
| EPS | -1.23 |
| Moving Average 50 Days | 2.24 |
| Moving Average 200 Days | 2.62 |
| Change | -0.13 |
NeurAxis to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
GlobeNewswire Inc.
May 27, 2025 12:00 PM GMT
CARMEL, Ind., May 27, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children an
NeurAxis Announces Closing of $5.0 Million Registered Direct Offering
GlobeNewswire Inc.
May 22, 2025 5:03 PM GMT
Strengthens Balance Sheet and Provides Growth CapitalCARMEL, Ind., May 22, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressi
NeurAxis Announces $5.0 Million Registered Direct Offering
GlobeNewswire Inc.
May 21, 2025 11:00 AM GMT
CARMEL, Ind., May 21, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children an